BIOPLEX IMPLANT 2002-121409

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,07 report with the FDA on 2005-06-02 for BIOPLEX IMPLANT 2002-121409 manufactured by Interpore Cross International.

Event Text Entries

[382198] A bioplex implant was fractured as it was being impacted during surgery. Another implant of the same type was used to complete the case uneventfully. There was no complication and/or injury to patient. Patient doing well.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2029012-2005-00023
MDR Report Key609957
Report Source05,07
Date Received2005-06-02
Date of Report2005-06-02
Date of Event2005-04-28
Date Mfgr Received2005-05-03
Device Manufacturer Date2004-09-01
Date Added to Maude2005-06-06
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactMARY CARVAJAL
Manufacturer Street181 TECHNOLOGY DR
Manufacturer CityIRVINE CA 92618
Manufacturer CountryUS
Manufacturer Postal92618
Manufacturer Phone9494533200
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameBIOPLEX IMPLANT
Generic NameCEMENT RESTRICTOR
Product CodeJDK
Date Received2005-06-02
Model NumberNA
Catalog Number2002-121409
Lot Number403909
ID NumberNA
Device Expiration Date2006-09-01
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrN
Implant FlagY
Date RemovedV
Device Sequence No1
Device Event Key599765
ManufacturerINTERPORE CROSS INTERNATIONAL
Manufacturer Address* IRVINE CA * US
Baseline Brand NameBIOPLEX IMPLANT
Baseline Generic NameCEMENT RESTRICTOR
Baseline Catalog No2002-121409
Baseline Shelf Life ContainedY
Baseline Shelf Life [Months]24
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK023908
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Other; 2. Required No Informationntervention 2005-06-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.